Cystic Fibrosis Foundation is categorized under Medical Research in Albuquerque, NM .
Cystic Fibrosis Foundation was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417200 by the NAICS.
If you are seeking more information, feel free to contact Amanda Bergamo, Executive Director at the company’s single location by writing to 4004 Carlisle Boulevard Ne # B, Albuquerque, New Mexico NM 87107 or by phoning (505) 883-1455. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cystic Fibrosis Foundation |
| Contact Person: | Amanda Bergamo, Executive Director |
| Address: | 4004 Carlisle Boulevard Ne # B, Albuquerque, New Mexico 87107 |
| Phone Number: | (505) 883-1455 |
| Website Address: | cff.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417200 |
| Share This Business: |
Cystic Fibrosis Foundation was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Amanda Bergamo, Executive Director for inquiries that concern Cystic Fibrosis Foundation by calling the company number (505) 883-1455, as your correspondence is most welcome. Additionally, the physical location of the single location of Cystic Fibrosis Foundation can be found at the coordinates 35.126267,-106.60405 as well as the street address 4004 Carlisle Boulevard Ne # B in Albuquerque, New Mexico 87107.
For its online presence, you may visit Cystic Fibrosis Foundation’s website at cff.org and engage with its social media outlets through on Twitter and on Facebook.